Form 4: Relay Therapeutics CFO Sells Shares to Cover Tax Obligations and Under 10b5-1 Plan

Thomas Catinazzo, CFO of Relay Therapeutics, sold shares to cover income tax withholding obligations and pursuant to a pre-arranged Rule 10b5-1 trading plan.

Summary

• On December 27, 2024, Thomas Catinazzo, the Chief Financial Officer of Relay Therapeutics, sold 299 shares of common stock at $4.38 per share to cover income tax withholding obligations upon the vesting of 992 shares of restricted stock units (RSUs).
• Additionally, Catinazzo sold 4,566 shares of common stock at a weighted average price of $4.42 per share under a pre-arranged Rule 10b5-1 trading plan adopted on February 15, 2024.
• Following these transactions, Catinazzo beneficially owns 299,226 shares of Relay Therapeutics, which includes 291,498 shares underlying RSUs.

Sentiment

Score: 5

Explanation: The sentiment is neutral. The filing simply reports routine transactions (tax obligation coverage and pre-planned sales). There's no indication of positive or negative sentiment towards the company's prospects.

Industry Context

Form 4 filings are standard disclosures required by the SEC when company insiders, like the CFO, trade their company's stock. These filings are closely watched by investors for insights into management's perspective on the company's valuation and future prospects. Sales to cover tax obligations are common and often have limited impact on the stock price, while sales under 10b5-1 plans are pre-arranged and provide some insulation from insider trading accusations.

Key Dates